{
  "ATHE": [
    {
      "author": "Benzinga Newsdesk",
      "content": "",
      "created_at": "2025-01-30T12:38:26Z",
      "headline": "Alterity Therapeutics Reveals Topline Results From ATH434-201 Randomized, Double-blind, Placebo-controlled Phase 2 Clinical Trial In Patients With Early-stage Multiple System Atrophy; Says Clinically Meaningful Benefit Observed At Both ATH434 Doses Studied",
      "id": 43333419,
      "images": [],
      "source": "benzinga",
      "summary": "",
      "symbols": [
        "ATHE"
      ],
      "updated_at": "2025-01-30T12:38:27Z",
      "url": "https://www.benzinga.com/news/25/01/43333419/alterity-therapeutics-reveals-topline-results-from-ath434-201-randomized-double-blind-placebo-contro",
      "added_at": "2025-01-30T12:40:18.493Z"
    }
  ],
  "TZUP": [
    {
      "author": "Benzinga Newsdesk",
      "content": "",
      "created_at": "2025-01-30T12:09:41Z",
      "headline": "Thumzup Media Corporation Says Advertiser Base Grew By 230% In 2024, Surpassing 600 Active Advertisers Across Diverse Industries",
      "id": 43332480,
      "images": [],
      "source": "benzinga",
      "summary": "",
      "symbols": [
        "TZUP"
      ],
      "updated_at": "2025-01-30T12:09:42Z",
      "url": "https://www.benzinga.com/news/25/01/43332480/thumzup-media-corporation-says-advertiser-base-grew-by-230-in-2024-surpassing-600-active-advertisers",
      "added_at": "2025-01-30T12:17:40.722Z"
    },
    {
      "author": "Benzinga Newsdesk",
      "content": "",
      "created_at": "2025-01-30T13:13:06Z",
      "headline": "Thumzup Embraces Cryptocurrency Strategy, Holding 19.106 BTC; Authorized To Invest Up To 90% Surplus Cash In BTC, Compensates Gig Workers With BTC, Explores Wider BTC Integration; AI And Blockchain Utilization Highlighted",
      "id": 43334726,
      "images": [],
      "source": "benzinga",
      "summary": "",
      "symbols": [
        "TZUP"
      ],
      "updated_at": "2025-01-30T13:13:07Z",
      "url": "https://www.benzinga.com/markets/cryptocurrency/25/01/43334726/thumzup-embraces-cryptocurrency-strategy-holding-19-106-btc-authorized-to-invest-up-to-90-",
      "added_at": "2025-01-30T15:16:16.791Z"
    }
  ],
  "KZIA": [
    {
      "author": "Benzinga Newsdesk",
      "content": "",
      "created_at": "2025-01-30T12:32:15Z",
      "headline": "Kazia Therapeutics Reports Regulatory Approval And Launch Of Clinical Trial Evaluating Combination Of Paxalisib And Immunotherapy In Patients With Advanced Breast Cancer",
      "id": 43333078,
      "images": [],
      "source": "benzinga",
      "summary": "",
      "symbols": [
        "KZIA"
      ],
      "updated_at": "2025-01-30T12:32:15Z",
      "url": "https://www.benzinga.com/news/25/01/43333078/kazia-therapeutics-reports-regulatory-approval-and-launch-of-clinical-trial-evaluating-combination-o",
      "added_at": "2025-01-30T12:35:18.481Z"
    }
  ],
  "ELAB": [
    {
      "author": "Benzinga Newsdesk",
      "content": "",
      "created_at": "2025-01-30T13:02:30Z",
      "headline": "PMGC Holdings' Northstrive Biosciences Initiates Study On EL-32 Alone And With Semaglutide For Obesity, Targeting Glycemic Control And Body Composition In Mice; Results Expected In 3-Months",
      "id": 43334153,
      "images": [],
      "source": "benzinga",
      "summary": "",
      "symbols": [
        "ELAB"
      ],
      "updated_at": "2025-01-30T13:02:30Z",
      "url": "https://www.benzinga.com/general/biotech/25/01/43334153/pmgc-holdings-northstrive-biosciences-initiates-study-on-el-32-alone-and-with-semaglutide-for-obe",
      "added_at": "2025-01-30T15:16:16.791Z"
    }
  ],
  "PLRZ": [
    {
      "author": "Benzinga Newsdesk",
      "content": "",
      "created_at": "2025-01-30T10:56:02Z",
      "headline": "Polyrizon Files Divisional Patent Application For Trap & Target Intranasal Drug Delivery Platform",
      "id": 43330097,
      "images": [],
      "source": "benzinga",
      "summary": "",
      "symbols": [
        "PLRZ"
      ],
      "updated_at": "2025-01-30T10:56:02Z",
      "url": "https://www.benzinga.com/news/25/01/43330097/polyrizon-files-divisional-patent-application-for-trap-target-intranasal-drug-delivery-platform",
      "added_at": "2025-01-30T15:16:17.089Z"
    }
  ],
  "AMOD": [
    {
      "author": "Benzinga Newsdesk",
      "content": "",
      "created_at": "2025-01-30T13:11:10Z",
      "headline": "Alpha Modus CEO Defends Company Amidst Market Speculation, Emphasizes Strong Fundamentals, Growth Strategy, And Shareholder Value Post-SPAC Transition; Criticizes Short-Term Focus In SPAC Market",
      "id": 43334710,
      "images": [],
      "source": "benzinga",
      "summary": "",
      "symbols": [
        "AMOD"
      ],
      "updated_at": "2025-01-30T13:11:10Z",
      "url": "https://www.benzinga.com/news/25/01/43334710/alpha-modus-ceo-defends-company-amidst-market-speculation-emphasizes-strong-fundamentals-growth-stra",
      "added_at": "2025-01-30T15:16:17.089Z"
    }
  ],
  "AMPG": [
    {
      "author": "Benzinga Newsdesk",
      "content": "",
      "created_at": "2025-01-30T13:51:35Z",
      "headline": "AmpliTech Group Announces USPTO Patent Receipt For Optimized 5G Front End Technology; More Patents Expected Q1 2025; Collaborating With Intellectual Property Experts To Assess The Technology's Valuation For Prompt Incorporation Into Its Balance Sheet",
      "id": 43336315,
      "images": [],
      "source": "benzinga",
      "summary": "",
      "symbols": [
        "AMPG"
      ],
      "updated_at": "2025-01-30T13:51:35Z",
      "url": "https://www.benzinga.com/news/25/01/43336315/amplitech-group-announces-uspto-patent-receipt-for-optimized-5g-front-end-technology-more-patents-ex",
      "added_at": "2025-01-30T15:16:17.089Z"
    }
  ],
  "ACMR": [
    {
      "author": "Benzinga Newsdesk",
      "content": "",
      "created_at": "2025-01-30T13:49:21Z",
      "headline": "Watching ACM Research Shares, Kerrisdale Capital Announces Long Position In Stock",
      "id": 43336273,
      "images": [],
      "source": "benzinga",
      "summary": "",
      "symbols": [
        "ACMR"
      ],
      "updated_at": "2025-01-30T13:49:21Z",
      "url": "https://www.benzinga.com/news/25/01/43336273/watching-acm-research-shares-kerrisdale-capital-announces-long-position-in-stock",
      "added_at": "2025-01-30T15:16:17.089Z"
    },
    {
      "author": "Adam Eckert",
      "content": "",
      "created_at": "2025-01-30T15:32:43Z",
      "headline": "ACM Research Stock Surges On Bullish Call From Kerrisdale Capital: 'Ultimate 10-Bagger'",
      "id": 43342074,
      "images": [
        {
          "size": "large",
          "url": "https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2025/01/30/ACM-Research-Shutterstock.jpeg"
        },
        {
          "size": "small",
          "url": "https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2025/01/30/ACM-Research-Shutterstock.jpeg"
        },
        {
          "size": "thumb",
          "url": "https://cdn.benzinga.com/files/imagecache/250x187xUP/images/story/2025/01/30/ACM-Research-Shutterstock.jpeg"
        }
      ],
      "source": "benzinga",
      "summary": "ACM Research Inc (NASDAQ:ACMR) shares are trading higher Thursday after short-selling investment firm Kerrisdale Capital announced a long position in the stock. ",
      "symbols": [
        "ACMR"
      ],
      "updated_at": "2025-01-30T15:32:43Z",
      "url": "https://www.benzinga.com/trading-ideas/movers/25/01/43342074/acm-research-stock-surges-on-bullish-call-from-kerrisdale-capital-ultimate-10-bagger",
      "added_at": "2025-01-30T15:35:10.759Z"
    }
  ],
  "STAI": [
    {
      "author": "Benzinga Newsdesk",
      "content": "",
      "created_at": "2025-01-30T13:34:09Z",
      "headline": "ScanTech AI Systems Deploys Its Security Screening Technology To Protect Multiple Nuclear Power Plants Operated By Ontario Power Generation",
      "id": 43335484,
      "images": [],
      "source": "benzinga",
      "summary": "",
      "symbols": [
        "STAI"
      ],
      "updated_at": "2025-01-30T13:34:10Z",
      "url": "https://www.benzinga.com/news/25/01/43335484/scantech-ai-systems-deploys-its-security-screening-technology-to-protect-multiple-nuclear-power-plan",
      "added_at": "2025-01-30T15:16:17.089Z"
    }
  ],
  "SPAI": [
    {
      "author": "Benzinga Newsdesk",
      "content": "",
      "created_at": "2025-01-30T13:09:11Z",
      "headline": "Safe Pro Enters MoU With NIBULON To Cooperate On Ukraine's Agricultural Crisis",
      "id": 43334589,
      "images": [],
      "source": "benzinga",
      "summary": "",
      "symbols": [
        "SPAI"
      ],
      "updated_at": "2025-01-30T13:09:12Z",
      "url": "https://www.benzinga.com/news/25/01/43334589/safe-pro-enters-mou-with-nibulon-to-cooperate-on-ukraines-agricultural-crisis",
      "added_at": "2025-01-30T15:16:17.089Z"
    }
  ],
  "CELZ": [
    {
      "author": "Benzinga Newsdesk",
      "content": "",
      "created_at": "2025-01-30T14:25:59Z",
      "headline": "Creative Medical Technology Holdings Announces Initial Safety, Tolerability, and Efficacy Data From First Cohort In Phase 1/2 Trial Of CELZ-201-DDT",
      "id": 43337845,
      "images": [],
      "source": "benzinga",
      "summary": "",
      "symbols": [
        "CELZ"
      ],
      "updated_at": "2025-01-30T14:26:00Z",
      "url": "https://www.benzinga.com/general/biotech/25/01/43337845/creative-medical-technology-holdings-announces-initial-safety-tolerability-and-efficacy-data-from",
      "added_at": "2025-01-30T15:16:17.388Z"
    }
  ],
  "BFLY": [
    {
      "author": "Benzinga Newsdesk",
      "content": "",
      "created_at": "2025-01-30T12:36:58Z",
      "headline": "Butterfly Network shares are trading lower after the company announced a $75.6 million public offering of class A common stock.",
      "id": 43333199,
      "images": [],
      "source": "benzinga",
      "summary": "",
      "symbols": [
        "BFLY"
      ],
      "updated_at": "2025-01-30T15:04:10Z",
      "url": "https://www.benzinga.com/wiim/25/01/43333199/butterfly-network-shares-are-trading-lower-after-the-company-announced-a-75-6-million-public-offerin",
      "added_at": "2025-01-30T15:16:17.388Z"
    },
    {
      "author": "Benzinga Newsdesk",
      "content": "",
      "created_at": "2025-01-30T05:57:48Z",
      "headline": "Reported Earlier, Butterfly Network Prices $75.6M Public Offering Of 24M Class A Common Stock At $3.15/Share",
      "id": 43327300,
      "images": [],
      "source": "benzinga",
      "summary": "",
      "symbols": [
        "BFLY"
      ],
      "updated_at": "2025-01-30T05:57:48Z",
      "url": "https://www.benzinga.com/news/25/01/43327300/reported-earlier-butterfly-network-prices-75-6m-public-offering-of-24m-class-a-common-stock-at-3-15s",
      "added_at": "2025-01-30T15:16:17.388Z"
    },
    {
      "author": "Benzinga Newsdesk",
      "content": "",
      "created_at": "2025-01-29T21:01:35Z",
      "headline": "Butterfly Network Announces Proposed Public Offering Of Common Stock; No Size Or Amount Disclosed",
      "id": 43318501,
      "images": [],
      "source": "benzinga",
      "summary": "",
      "symbols": [
        "BFLY"
      ],
      "updated_at": "2025-01-29T21:01:36Z",
      "url": "https://www.benzinga.com/news/25/01/43318501/butterfly-network-announces-proposed-public-offering-of-common-stock-no-size-or-amount-disclosed",
      "added_at": "2025-01-30T15:16:17.389Z"
    }
  ],
  "NUWE": [
    {
      "author": "Benzinga Newsdesk",
      "content": "",
      "created_at": "2025-01-30T14:55:53Z",
      "headline": "On January 29, Nuwellis Posted On X \"Big news! As of January 1, 2025, the reimbursement for Aquadex just quadrupled under APC 5242, making it a game-changer for outpatient care! Are you ready to lead the way in patient treatment and maximize your returns?....\"",
      "id": 43339530,
      "images": [],
      "source": "benzinga",
      "summary": "",
      "symbols": [
        "NUWE"
      ],
      "updated_at": "2025-01-30T14:55:54Z",
      "url": "https://www.benzinga.com/news/25/01/43339530/on-january-29-nuwellis-posted-on-x-big-news-as-of-january-1-2025-the-reimbursement-for-aquadex-just",
      "added_at": "2025-01-30T15:16:17.388Z"
    }
  ],
  "PL": [
    {
      "author": "Benzinga Newsdesk",
      "content": "",
      "created_at": "2025-01-30T14:26:24Z",
      "headline": "JMP Securities Maintains Market Outperform on Planet Labs, Raises Price Target to $6.5",
      "id": 43337912,
      "images": [],
      "source": "benzinga",
      "summary": "",
      "symbols": [
        "PL"
      ],
      "updated_at": "2025-01-30T14:26:24Z",
      "url": "https://www.benzinga.com/news/25/01/43337912/jmp-securities-maintains-market-outperform-on-planet-labs-raises-price-target-to-6-5",
      "added_at": "2025-01-30T15:16:17.388Z"
    },
    {
      "author": "Benzinga Newsdesk",
      "content": "",
      "created_at": "2025-01-30T13:03:39Z",
      "headline": "Northland Capital Markets Maintains Outperform on Planet Labs, Raises Price Target to $7",
      "id": 43334195,
      "images": [],
      "source": "benzinga",
      "summary": "",
      "symbols": [
        "PL"
      ],
      "updated_at": "2025-01-30T13:03:40Z",
      "url": "https://www.benzinga.com/news/25/01/43334195/northland-capital-markets-maintains-outperform-on-planet-labs-raises-price-target-to-7",
      "added_at": "2025-01-30T15:16:17.388Z"
    },
    {
      "author": "Benzinga Insights",
      "content": "",
      "created_at": "2025-01-30T12:00:31Z",
      "headline": "Beyond The Numbers: 8 Analysts Discuss Planet Labs Stock",
      "id": 43331866,
      "images": [
        {
          "size": "large",
          "url": "https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2023/analyst_ratings_image_3.png"
        },
        {
          "size": "small",
          "url": "https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2023/analyst_ratings_image_3.png"
        },
        {
          "size": "thumb",
          "url": "https://cdn.benzinga.com/files/imagecache/250x187xUP/images/story/2023/analyst_ratings_image_3.png"
        }
      ],
      "source": "benzinga",
      "summary": " ",
      "symbols": [
        "PL"
      ],
      "updated_at": "2025-01-30T12:00:31Z",
      "url": "https://www.benzinga.com/insights/analyst-ratings/25/01/43331866/beyond-the-numbers-8-analysts-discuss-planet-labs-stock",
      "added_at": "2025-01-30T15:16:17.388Z"
    },
    {
      "author": "Benzinga Newsdesk",
      "content": "",
      "created_at": "2025-01-30T10:39:57Z",
      "headline": "Needham Maintains Buy on Planet Labs, Raises Price Target to $8",
      "id": 43329975,
      "images": [],
      "source": "benzinga",
      "summary": "",
      "symbols": [
        "PL"
      ],
      "updated_at": "2025-01-30T10:39:57Z",
      "url": "https://www.benzinga.com/news/25/01/43329975/needham-maintains-buy-on-planet-labs-raises-price-target-to-8",
      "added_at": "2025-01-30T15:16:17.388Z"
    }
  ],
  "BBAI": [
    {
      "author": "Benzinga Newsdesk",
      "content": "",
      "created_at": "2025-01-30T14:17:37Z",
      "headline": "BigBear.ai Has Been Awarded An Indefinite Delivery/Indefinite Quantity Contract Under The U.S. Department Of Navy's Seaport Next Generation Program",
      "id": 43337659,
      "images": [],
      "source": "benzinga",
      "summary": "",
      "symbols": [
        "BBAI"
      ],
      "updated_at": "2025-01-30T14:17:37Z",
      "url": "https://www.benzinga.com/news/25/01/43337659/bigbear-ai-has-been-awarded-an-indefinite-deliveryindefinite-quantity-contract-under-the-u-s-departm",
      "added_at": "2025-01-30T15:16:17.388Z"
    }
  ],
  "WOLF": [
    {
      "author": "Benzinga Newsdesk",
      "content": "",
      "created_at": "2025-01-30T13:27:57Z",
      "headline": "Piper Sandler Maintains Overweight on Wolfspeed, Lowers Price Target to $10",
      "id": 43335162,
      "images": [],
      "source": "benzinga",
      "summary": "",
      "symbols": [
        "WOLF"
      ],
      "updated_at": "2025-01-30T13:27:57Z",
      "url": "https://www.benzinga.com/news/25/01/43335162/piper-sandler-maintains-overweight-on-wolfspeed-lowers-price-target-to-10",
      "added_at": "2025-01-30T15:16:17.388Z"
    },
    {
      "author": "Benzinga Insights",
      "content": "",
      "created_at": "2025-01-29T21:40:55Z",
      "headline": "Wolfspeed Q2 Earnings Assessment",
      "id": 43321035,
      "images": [
        {
          "size": "large",
          "url": "https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2023/analyst_ratings_image_1.jpeg"
        },
        {
          "size": "small",
          "url": "https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2023/analyst_ratings_image_1.jpeg"
        },
        {
          "size": "thumb",
          "url": "https://cdn.benzinga.com/files/imagecache/250x187xUP/images/story/2023/analyst_ratings_image_1.jpeg"
        }
      ],
      "source": "benzinga",
      "summary": " ",
      "symbols": [
        "WOLF"
      ],
      "updated_at": "2025-01-29T21:40:56Z",
      "url": "https://www.benzinga.com/insights/earnings/25/01/43321035/wolfspeed-q2-earnings-assessment",
      "added_at": "2025-01-30T15:16:17.388Z"
    },
    {
      "author": "Benzinga Insights",
      "content": "",
      "created_at": "2025-01-29T21:36:08Z",
      "headline": "Wolfspeed: Q2 Earnings Insights",
      "id": 43320735,
      "images": [
        {
          "size": "large",
          "url": "https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2023/analyst_ratings_image_0.png"
        },
        {
          "size": "small",
          "url": "https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2023/analyst_ratings_image_0.png"
        },
        {
          "size": "thumb",
          "url": "https://cdn.benzinga.com/files/imagecache/250x187xUP/images/story/2023/analyst_ratings_image_0.png"
        }
      ],
      "source": "benzinga",
      "summary": " ",
      "symbols": [
        "WOLF"
      ],
      "updated_at": "2025-01-29T21:36:08Z",
      "url": "https://www.benzinga.com/insights/earnings/25/01/43320735/wolfspeed-q2-earnings-insights",
      "added_at": "2025-01-30T15:16:17.388Z"
    },
    {
      "author": "Benzinga Insights",
      "content": "",
      "created_at": "2025-01-29T21:25:24Z",
      "headline": "Insights into Wolfspeed Q2 Earnings",
      "id": 43319861,
      "images": [
        {
          "size": "large",
          "url": "https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2023/analyst_ratings_image_3.png"
        },
        {
          "size": "small",
          "url": "https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2023/analyst_ratings_image_3.png"
        },
        {
          "size": "thumb",
          "url": "https://cdn.benzinga.com/files/imagecache/250x187xUP/images/story/2023/analyst_ratings_image_3.png"
        }
      ],
      "source": "benzinga",
      "summary": " ",
      "symbols": [
        "WOLF"
      ],
      "updated_at": "2025-01-29T21:25:25Z",
      "url": "https://www.benzinga.com/insights/earnings/25/01/43319861/insights-into-wolfspeed-q2-earnings",
      "added_at": "2025-01-30T15:16:17.388Z"
    },
    {
      "author": "Benzinga Newsdesk",
      "content": "",
      "created_at": "2025-01-29T21:13:53Z",
      "headline": "Wolfspeed Q2 2025 Adj EPS $(0.95) Beats $(1.02) Estimate, Sales $181.00M Beat $179.90M Estimate",
      "id": 43319173,
      "images": [],
      "source": "benzinga",
      "summary": "",
      "symbols": [
        "WOLF"
      ],
      "updated_at": "2025-01-29T21:13:53Z",
      "url": "https://www.benzinga.com/news/earnings/25/01/43319173/wolfspeed-q2-2025-adj-eps-0-95-beats-1-02-estimate-sales-181-00m-beat-179-90m-estimate",
      "added_at": "2025-01-30T15:16:17.388Z"
    },
    {
      "author": "Benzinga Insights",
      "content": "",
      "created_at": "2025-01-29T16:30:26Z",
      "headline": "(WOLF) - Analyzing Wolfspeed's Short Interest",
      "id": 43310374,
      "images": [
        {
          "size": "large",
          "url": "https://cdn.benzinga.com/files/imagecache/2048x1536xUP/images/story/2023/movers_image_0.jpeg"
        },
        {
          "size": "small",
          "url": "https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2023/movers_image_0.jpeg"
        },
        {
          "size": "thumb",
          "url": "https://cdn.benzinga.com/files/imagecache/250x187xUP/images/story/2023/movers_image_0.jpeg"
        }
      ],
      "source": "benzinga",
      "summary": " ",
      "symbols": [
        "WOLF"
      ],
      "updated_at": "2025-01-29T16:30:27Z",
      "url": "https://www.benzinga.com/insights/short-sellers/25/01/43310374/wolf-analyzing-wolfspeeds-short-interest",
      "added_at": "2025-01-30T15:16:17.389Z"
    },
    {
      "author": "Benzinga Newsdesk",
      "content": "",
      "created_at": "2025-01-30T16:02:16Z",
      "headline": "Goldman Sachs Maintains Buy on Wolfspeed, Lowers Price Target to $15",
      "id": 43343534,
      "images": [],
      "source": "benzinga",
      "summary": "",
      "symbols": [
        "WOLF"
      ],
      "updated_at": "2025-01-30T16:02:16Z",
      "url": "https://www.benzinga.com/news/25/01/43343534/goldman-sachs-maintains-buy-on-wolfspeed-lowers-price-target-to-15",
      "added_at": "2025-01-30T16:16:58.162Z"
    }
  ]
}